Dentist

An apple cider vinegar drink a day? New study shows it might help weight loss

Retrieved on: 
星期三, 三月 13, 2024

An experimental study, released today, looks into whether apple cider vinegar could be effective for weight loss, reduce blood glucose levels and reduce blood lipids (cholesterol and triglycerides).

Key Points: 
  • An experimental study, released today, looks into whether apple cider vinegar could be effective for weight loss, reduce blood glucose levels and reduce blood lipids (cholesterol and triglycerides).
  • The results suggest it could reduce all three – but it might not be as simple as downing an apple cider vinegar drink a day.

What did they do?

  • A control group consumed an inactive drink (a placebo) made (from lactic acid added to water) to look and taste the same.
  • The study was also double-blinded, which means neither the participants or the scientists involved with collecting the data knew who was in which group.

So, what did they find?

  • After a period of three months apple cider vinegar consumption was linked with significant falls in body weight and body mass index (BMI).
  • On average, those who drank apple cider vinegar during that period lost 6–8kg in weight and reduced their BMI by 2.7–3 points, depending on the dose.
  • The authors also report significant decreases in levels of blood glucose, triglycerides, and cholesterol in the apple cider groups.

Is this good news?

  • Firstly, study participants were aged from 12 to 25, so we can’t say whether the results could apply to everyone.
  • And while the researchers kept records of the participants’ diet and exercise during the study, these were not published in the paper.
  • This could be important and influence results if people who did not lose weight quit due to lack of motivation.


Read more:
Turns out the viral 'Sleepy Girl Mocktail' is backed by science. Should you try it?

Any other concerns?


Apple cider vinegar is acidic and there are concerns it may erode tooth enamel. This can be a problem with any acidic beverages, including fizzy drinks, lemon water and orange juice. To minimise the risk of acid erosion some dentists recommend the following after drinking acidic drinks:

Read more:
Apple cider vinegar: is drinking this popular home remedy bad for your teeth? A dentist explains

Down the hatch?

  • This study provides us with some evidence of a link between apple cider vinegar and weight loss.
  • This would provide more robust evidence that apple cider vinegar could be a useful aid for weight loss.


Evangeline Mantzioris is affiliated with Alliance for Research in Nutrition, Exercise and Activity (ARENA) at the University of South Australia. Evangeline Mantzioris has received funding from the National Health and Medical Research Council, and has been appointed to the National Health and Medical Research Council Dietary Guideline Expert Committee.

AXLE Announces Dentistry Software for Streamlining Dental Care

Retrieved on: 
星期三, 三月 6, 2024

Manage, analyze, and grow - AXLE is here to help dental practices capitalize on AI and automation to boost retention and production.

Key Points: 
  • Defined by an agile, customer-centric design, the dental platform allows dental professionals to maintain a simple, unified hub for their management tasks and patient care.
  • Since its launch in 2020, AXLE has been at the forefront of revolutionizing dental care through AI-powered automated solutions .
  • By streamlining operations, from scheduling to billing, analytics, and more, the dental platform has solidified its position in the dental industry.
  • Download the AXLE app or visit https://meetaxle.com/ to learn more about how AXLE is revolutionizing dental experiences for patients and providers.

Q&M Dental Group recorded growth in both Revenue and Net Profit after tax attributable to parent of S$182.7 million and S$11.5 million respectively for FY2023

Retrieved on: 
星期五, 三月 1, 2024

Comparing FY2023 with FY2022, share of loss in Aoxin Q & M, decreased by S$0.5 million for the same reason give above.

Key Points: 
  • Comparing FY2023 with FY2022, share of loss in Aoxin Q & M, decreased by S$0.5 million for the same reason give above.
  • This is mainly attributable to operating cash flow before changes in working capital offset by increase on working capital.
  • As at 31 December 2023, Q & M has cash and cash equivalents of S$34.0 million and bank borrowings plus finance leases amounting to S$80.3 million.
  • Net Aset Value attributable to owners of parent is S$99.1 million as at 31 December 2023 compared to S$96.5 million a year ago, an increase of 3%.

INMODE LTD. (NASDAQ: INMD) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against InMode Ltd.

Retrieved on: 
星期一, 三月 11, 2024

If you purchased or acquired InMode common stock, and/or would like to discuss your legal rights and options please visit InMode Ltd.

Key Points: 
  • If you purchased or acquired InMode common stock, and/or would like to discuss your legal rights and options please visit InMode Ltd.
  • If you wish to serve as lead plaintiff, you must move the Court no later than April 15, 2024.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against NYCB, LuxUrban, InMode, and Lantronix and Encourages Investors to Contact the Firm

Retrieved on: 
星期日, 三月 10, 2024

NYCB is a large commercial-real estate lender in the New York City market area, where it specializes in rent-regulated, non-luxury apartment buildings.

Key Points: 
  • NYCB is a large commercial-real estate lender in the New York City market area, where it specializes in rent-regulated, non-luxury apartment buildings.
  • NYCB is engaged in several national businesses, including multi-family lending, mortgage originations and servicing, and warehouse lending.
  • On January 31, 2024, before the market opened, NYCB announced its fiscal fourth quarter 2023 financial results.
  • Following these disclosures, Lantronix's stock price fell $1.89 per share, or 32.53%, to close at $3.92 per share on February 9, 2024.

Benevis Celebrates Dental Assistants Recognition Week

Retrieved on: 
星期五, 三月 8, 2024

Atlanta, GA, March 08, 2024 (GLOBE NEWSWIRE) -- Benevis , a leading dental healthcare and orthodontics delivery organization committed to providing quality care to underserved communities, celebrates Dental Assistants Recognition Week, March 3 through March 9, 2024.

Key Points: 
  • Atlanta, GA, March 08, 2024 (GLOBE NEWSWIRE) -- Benevis , a leading dental healthcare and orthodontics delivery organization committed to providing quality care to underserved communities, celebrates Dental Assistants Recognition Week, March 3 through March 9, 2024.
  • "We are honored to recognize the many wonderful contributions of our 750 Dental Assistants during this special celebratory week.
  • To honor Dental Assistants Recognition Week, Benevis has provided each office with a stipend to organize a personalized celebration for the Dental Assistants.
  • For Dental Assistants and dental professionals interested in joining Benevis, visit https://careers.benevis.com/careers for more information.

INMD INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that InMode Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Retrieved on: 
星期三, 三月 6, 2024

InMode is a global provider of aesthetic medical devices and technology including devices purporting to offer body sculpting and other rejuvenation technologies.

Key Points: 
  • InMode is a global provider of aesthetic medical devices and technology including devices purporting to offer body sculpting and other rejuvenation technologies.
  • Specifically, Defendants repeatedly touted the demand for InMode’s devices and told investors that those devices were never sold at a discount.
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660.
  • Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against InMode, Lantronix, Palo Alto Networks, and Snowflake and Encourages Investors to Contact the Firm

Retrieved on: 
星期二, 三月 5, 2024

InMode is a global provider of aesthetic medical devices and technology, including devices purporting to offer body sculpting and other rejuvenation technologies.

Key Points: 
  • InMode is a global provider of aesthetic medical devices and technology, including devices purporting to offer body sculpting and other rejuvenation technologies.
  • Specifically, Defendants repeatedly touted the demand for InMode’s devices and told investors that those devices were never sold at a discount.
  • The customers also stated that InMode offered to replace defective products on the condition of signing confidentiality agreements with non-disparagement clauses.
  • which lowered credit consumption.”  On this news, the price of Snowflake Class A common stock fell nearly 28% over several trading sessions, damaging investors.

INMODE LTD. (NASDAQ: INMD) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against InMode Ltd.

Retrieved on: 
星期一, 三月 4, 2024

If you purchased or acquired InMode common stock, and/or would like to discuss your legal rights and options please visit InMode Ltd.

Key Points: 
  • If you purchased or acquired InMode common stock, and/or would like to discuss your legal rights and options please visit InMode Ltd.
  • If you wish to serve as lead plaintiff, you must move the Court no later than April 15, 2024.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against InMode, Lantronix, and Palo Alto Networks and Encourages Investors to Contact the Firm

Retrieved on: 
星期六, 三月 2, 2024

InMode is a global provider of aesthetic medical devices and technology, including devices purporting to offer body sculpting and other rejuvenation technologies.

Key Points: 
  • InMode is a global provider of aesthetic medical devices and technology, including devices purporting to offer body sculpting and other rejuvenation technologies.
  • Specifically, Defendants repeatedly touted the demand for InMode’s devices and told investors that those devices were never sold at a discount.
  • On this news, the price of Palo Alto Networks, Inc. common stock declined by $104.12 per share, or approximately 28%, on February 21, 2024.
  • For more information on the Palo Alto Networks class action go to: https://bespc.com/cases/PANW